Hisamitsu Pharmaceutical Co., Inc. EBIT Margin for the year ending February 28, 2025: 18.40%

Hisamitsu Pharmaceutical Co., Inc. EBIT Margin is 18.40% for the year ending February 28, 2025, a 35.82% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Hisamitsu Pharmaceutical Co., Inc. EBIT Margin for the year ending February 29, 2024 was 13.55%, a 49.90% change year over year.
  • Hisamitsu Pharmaceutical Co., Inc. EBIT Margin for the year ending February 28, 2023 was 9.04%, a 16.37% change year over year.
  • Hisamitsu Pharmaceutical Co., Inc. EBIT Margin for the year ending February 28, 2022 was 7.77%, a -16.65% change year over year.
  • Hisamitsu Pharmaceutical Co., Inc. EBIT Margin for the year ending February 28, 2021 was 9.32%, a -42.19% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin